市場調査レポート
商品コード
1347411
幹細胞バンク市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
幹細胞バンク市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
世界の幹細胞バンクの市場規模は2022年に74億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて8.1%の成長率(CAGR)を示し、2028年には117億米ドルに達すると予測しています。
幹細胞バンクは、次世代幹細胞治療の中で最も有望かつ急成長している分野の一つです。幹細胞バンクとは、幹細胞を抽出、凍結、保存し、将来使用する可能性を秘めたプロセスです。幹細胞は、胚、臍帯、臍帯血、胎盤、骨髄などから採取されます。これらの細胞は、糖尿病、サラセミア、白血病、鎌状赤血球貧血、心疾患など、さまざまな病気の治療に用いられています。さらに、血小板、赤血球、白血球の生成にも用いられます。幹細胞の再生可能性は、組織工学、遺伝子治療、再生医療への応用につながっています。
医学の進歩により人間の平均寿命が延びた一方で、人間の老化は依然としていくつかの病気と関連しています。従って、老年人口の増加は、今後数年間における幹細胞治療の需要を押し上げると思われます。
規制当局や非政府組織(NGO)は、先進国・新興国を問わず、幹細胞の治療ポテンシャルについて消費者に認識を浸透させるためのイニシアチブをとっており、幹細胞バンク市場の成長に影響を与えています。
出生率の上昇により、世界中で子供の数が増加しています。このことは、造血幹細胞を含む乳児のへその緒を保存するための有利な機会を提供しています。
市場の成長を促進するその他の要因としては、可処分所得の増加、幹細胞研究における臨床試験の承認の増加、慢性疾患の有病率の増加、技術の進歩などが挙げられます。
The global stem cell banking market size reached US$ 7.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.
Stem cell banking is one of the most promising as well as the fastest growing segment of the next-generation stem cell therapy. It is the process of extracting, freezing and storing stem cells for potential future use. Some of the sources through which stem cells are obtained include embryo, umbilical cord, cord blood, placenta and bone marrow. These cells are used for treating a number of different diseases including diabetes, thalassemia, leukemia, sickle cell anemia and cardiac diseases. Moreover, they are also employed for generating platelets, red blood cells and white blood cells. The potential of stem cells to regenerate has led to their applications in tissue engineering, gene therapy and regenerative medicines.
While the average human life expectancy has increased owing to the advancements in medical science, human aging is still associated with several diseases. Thus, the elevating count of geriatric population will drive the demand for stem cell therapy in the coming years.
Regulatory authorities as well as non-governmental organizations (NGO), across both developed and emerging regions, are taking initiatives for instilling awareness amongst consumers about the therapeutic potentials of stem cells, thereby influencing the stem cell banking market growth.
Increasing fertility rates has led to a rise in the number of children across the globe. This offers lucrative opportunities for preserving the umbilical cord of infants which contains hematopoietic (blood) stem cells.
Some of the other factors which are catalyzing the growth of the market include escalating disposable incomes, increasing approval of clinical trials in stem cell research, growing prevalence of chronic diseases and technological advancements.
IMARC Group provides an analysis of the key trends in each segment of the global stem cell banking market report, along with forecasts at the global and regional levels from 2023-2028. Our report has categorized the market based on product type, service type, bank type, utilization and application.
Adult Stem Cells
Human Embryonic Cells
IPS Cells
On the basis of product types, the market has been segmented as adult stem cells, human embryonic cells and IPS cells. Presently, adult stem cells account for the majority of the market share as they help in repairing damaged tissues via cell division. In addition to this, adult stem cells offer advantages like ease of harvesting, high acceptance in the human body and effectiveness in tissue generation.
Sample Preservation and Storage
Sample Analysis
Sample Processing
Sample Collection and Transportation
Based on service types, the market has been segmented as sample preservation and storage, sample analysis, sample processing, and sample collection and transportation.
Private
Public
Based on the bank type, the market has been segregated as private and public stem cell banks. Private stem cell banks currently dominate the market, holding the largest share.
Used
Unused
Based on the utilization, the market has been segregated as used and unused.
Personalized Banking Applications
Research Applications
Clinical Applications
On the basis of application, the market has been segmented as personalized banking applications, research applications and clinical applications.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
On a geographical front, North America enjoys the leading position in the global stem cell banking market on account of advancements in medical infrastructure and availability of federal funding for stem cell research. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
CBR Systems Inc.
China Cord Blood Corporation
Cordlife
Cordvida
Cryo-Cell International, Inc.
Cryo-Save AG (A Group of Esperite)
Cryoviva India
Lifecell
Smart Cells International Ltd
Viacord